SC Filed 2019-02-14 Event — SEC 0001193125-19-039148 →

POLARIS VENTURE PARTNERS IV LP → Dare Bioscience, Inc. DARE

Stake: — Shares: —

Composite Decision Signal · PASS (LOW BASE-RATE EDGE) Conviction Score: 21/100

Passive Schedule 13G filer baseline
Elevated short days-to-cover (10.3 DTC)
Short interest building (+24.0% vs prior settlement)

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

12 13D/G filings on this issuer

11 other filings besides this one

Filer Track Record

2 filings by this filer

1 other filing in the data moat

Short Interest · settle 2026-10-15

DTC 10.30

1,143,697 shares short · +24.0% vs prior

Other 13D/G Filings on Dare Bioscience, Inc.

Filed	Form	Filer	Stake	Shares
2026-08-28	SCHEDULE 13G	Lind Global Fund III LP	—	—	view →
2026-08-24	SCHEDULE 13G	L1 Capital Global Opportunities Master Fund, Ltd.	—	—	view →
2020-04-01	SC	HAWLEY ROGER	—	—	view →
2020-02-21	SC	Dare Bioscience, Inc.	—	—	view →
2019-12-09	SC	Dare Bioscience, Inc.	—	—	view →
2019-04-16	SC	Walters Mark	—	—	view →
2019-04-15	SC	HAWLEY ROGER	—	—	view →
2019-04-15	SC	Walters-Hoffert Lisa	—	—	view →
2019-04-15	SC	JOHNSON SABRINA MARTUCCI	—	—	view →
2019-02-14	SC	Polaris Venture Partners V, L.P.	—	—	view →
2019-02-14	SC	Crane Alan L	—	—	view →

Other Filings by POLARIS VENTURE PARTNERS IV LP

Filed	Form	Issuer	Stake	Shares
2019-02-14	SC	ALIMERA SCIENCES INC	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.

See pricing →